PL2374461T3 - Piroksykam do profilaktycznego i terapeutycznego leczenia zakażeń opryszczką - Google Patents

Piroksykam do profilaktycznego i terapeutycznego leczenia zakażeń opryszczką

Info

Publication number
PL2374461T3
PL2374461T3 PL11001816T PL11001816T PL2374461T3 PL 2374461 T3 PL2374461 T3 PL 2374461T3 PL 11001816 T PL11001816 T PL 11001816T PL 11001816 T PL11001816 T PL 11001816T PL 2374461 T3 PL2374461 T3 PL 2374461T3
Authority
PL
Poland
Prior art keywords
piroxicam
prophylactic
therapeutic treatment
herpes infections
herpes
Prior art date
Application number
PL11001816T
Other languages
English (en)
Polish (pl)
Inventor
Jan Slomianny
Original Assignee
Hov Gmbh
Jan Slomianny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hov Gmbh, Jan Slomianny filed Critical Hov Gmbh
Publication of PL2374461T3 publication Critical patent/PL2374461T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11001816T 2010-04-08 2011-03-04 Piroksykam do profilaktycznego i terapeutycznego leczenia zakażeń opryszczką PL2374461T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010014290A DE102010014290A1 (de) 2010-04-08 2010-04-08 Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
EP11001816.5A EP2374461B1 (de) 2010-04-08 2011-03-04 Piroxicam zur prohylaktischen und therapeutischen Behandlung von Herpes-Infektionen

Publications (1)

Publication Number Publication Date
PL2374461T3 true PL2374461T3 (pl) 2017-08-31

Family

ID=43970974

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11001816T PL2374461T3 (pl) 2010-04-08 2011-03-04 Piroksykam do profilaktycznego i terapeutycznego leczenia zakażeń opryszczką

Country Status (11)

Country Link
US (2) US20130190301A1 (enExample)
EP (1) EP2374461B1 (enExample)
JP (1) JP6158077B6 (enExample)
CN (1) CN103153312B (enExample)
CA (1) CA2795334C (enExample)
DE (1) DE102010014290A1 (enExample)
DK (1) DK2374461T3 (enExample)
ES (1) ES2612584T3 (enExample)
PL (1) PL2374461T3 (enExample)
RU (1) RU2555765C2 (enExample)
WO (1) WO2011124366A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010014290A1 (de) * 2010-04-08 2011-10-13 Hans Otto Meyer zu Spelbrink Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
DE102013003756A1 (de) 2013-03-06 2014-09-11 DeaValorum UG (haftungsbeschränkt) Piroxicam zur prophylaktischen und therapeutischen Behandlung von CMV-Infektionen
DE102013014787A1 (de) 2013-09-09 2015-03-12 Dauphine UG (haftungsbeschränkt) Mittel zur prophylaktischen und therapeutischen Behandlung von EHV-Infektionen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
IT1230922B (it) * 1989-06-23 1991-11-08 Giuseppe De Benedittis Composizione per il trattamento della nevralgia erpetica acuta e della nevralgia post erpetica
ES2059869T3 (es) * 1990-04-26 1994-11-16 Sagitta Arzneimittel Gmbh Preparado farmaceutico que contiene piroxicam para uso topico.
JP3031990B2 (ja) * 1990-10-19 2000-04-10 同仁医薬化工株式会社 消炎鎮痛クリーム剤組成物
RU2182016C2 (ru) * 1997-03-20 2002-05-10 Панацея Биотек Лтд. Спазмолитическая композиция, способ получения спазмолитической композиции
DE10300222A1 (de) * 2003-01-03 2004-07-15 MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
DE102010014290A1 (de) * 2010-04-08 2011-10-13 Hans Otto Meyer zu Spelbrink Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen

Also Published As

Publication number Publication date
CN103153312A (zh) 2013-06-12
ES2612584T3 (es) 2017-05-17
CA2795334A1 (en) 2011-10-13
US20130190301A1 (en) 2013-07-25
DE102010014290A1 (de) 2011-10-13
JP6158077B2 (ja) 2017-07-05
EP2374461A1 (de) 2011-10-12
DK2374461T3 (en) 2017-02-06
JP6158077B6 (ja) 2018-08-29
WO2011124366A1 (de) 2011-10-13
CA2795334C (en) 2015-06-09
CN103153312B (zh) 2015-07-22
JP2013523789A (ja) 2013-06-17
RU2555765C2 (ru) 2015-07-10
RU2012147474A (ru) 2014-05-20
EP2374461B1 (de) 2016-10-26
US20140148447A1 (en) 2014-05-29

Similar Documents

Publication Publication Date Title
IL261768B (en) Devices and methods for tissue treatment
PL2532367T3 (pl) Środek farmaceutyczny do leczenia i/lub zapobiegania nowotworu
SMT201800064T1 (it) Derivati di pirrolopirimidina per l'uso del trattamento di infezioni virali
GB201302653D0 (en) Pharmaceutical compositions and methods of treatment
EP2640316A4 (en) FABRIC BACKUP DEVICES AND USE METHOD THEREFOR
AP3480A (en) Phosphaplatins and their use for treatment of cancers
EP2387407A4 (en) MEDICAMENT FOR THE TREATMENT OF PAIN AND INFLAMMATION
IL238126A0 (en) Compositions for the treatment and prevention of obesity
ZA201207957B (en) Prevention and treatment of gastrointestinal infection in mammals
PL2678307T3 (pl) Zastosowanie pochodnych poliaminoizoprenylu w leczeniu antybiotykami lub środkami antyseptycznymi
PL2374461T3 (pl) Piroksykam do profilaktycznego i terapeutycznego leczenia zakażeń opryszczką
SI2640728T1 (sl) Novi derivati monenzina za zdravljenje in preprečevanje protozojskih infekcij
PT2531124T (pt) Dispositivos para o tratamento de lesões cutâneas
IL216717A0 (en) USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES
EP2640468A4 (en) ADMINISTRATIVE AND TREATMENT PROCEDURES
EP2404611A4 (en) Peptide for the prophylactic or therapeutic treatment of skin tumors, in the initial stages
AU2009900091A0 (en) Methods of treatment and prophylaxis
AU2010902343A0 (en) Compositions for Therapy and Methods of Treatment
GB201020304D0 (en) Treatment and prevention of pain
AU2010905239A0 (en) Method of treatment and prophylaxis
AU2010904813A0 (en) Skin cancer prevention and treatment
AU2010900897A0 (en) Skin cancer prevention and treatment
IL221238A0 (en) Pharmaceutical compositions and methods for the treatment and prevention of cancer
AU2012902296A0 (en) Compositions for Therapy and Methods of Treatment
HK1170238A (en) Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer